دورية أكاديمية
Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers
العنوان: | Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers |
---|---|
المؤلفون: | Ritu Arya, MD, Daniel Hong, MD, Olivia Schultz, BA, Jessica M. Jutzy, MD, Katherine Cotangco, MD, Pamela Peters, MD, Ellen W. Daily, MD, Anne R. McCall, MD, Andrew R. Howard, MD, Yasmin Hasan, MD, Rajul Kothari, MD, Christina H. Son, MD |
المصدر: | Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100833- (2022) |
بيانات النشر: | Elsevier, 2022. |
سنة النشر: | 2022 |
المجموعة: | LCC:Medical physics. Medical radiology. Nuclear medicine LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Purpose: Patients with cervical cancer are at high risk for opioid use. This study aimed to characterize opioid prescribing patterns at 2 urban hospitals. Methods and Materials: Data from patients with cervical cancer treated with curative intent from 2011 to 2018 were retrospectively collected. Women with unrelated chronic opioid use before diagnosis, persistent/recurrent disease at 3 months after initiation of treatment, or initiation of opioids >6 months after treatment were excluded. Demographics, disease characteristics, treatment, and outpatient prescription practices were collected. Endpoints included duration of opioid use ≥6 and ≥12 months. Results: There were 106 women included, of whom 83% received definitive radiation. Most patients (n = 91, 85.8%) received outpatient opioids. Most common timing of prescriptions were before cancer therapy (35.9%), postprocedure (26.4%), and during radiation therapy (17.0%). Median duration was 3 (interquartile range, 1-11) months; 35.2% of these patients received opioids ≥6 months and 22% received opioids ≥12 months. Greater International Federation of Gynaecology and Obstetrics (FIGO) stage, recurrent/residual disease, initiation of opioids before treatment, history of depression or anxiety, and use of gabapentin or steroids were associated with long-term opioid use. Conclusions: Most patients were prescribed outpatient opioids, many of whom used opioids for 12 months. Improvement in provider communication and education, increased posttreatment monitoring, and further evaluation of nonopioid therapies are needed in this patient population to reduce long-term opioid use. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2452-1094 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2452109421001913; https://doaj.org/toc/2452-1094 |
DOI: | 10.1016/j.adro.2021.100833 |
URL الوصول: | https://doaj.org/article/b78482b6df2b44838d2ea0f26166ad48 |
رقم الأكسشن: | edsdoj.b78482b6df2b44838d2ea0f26166ad48 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 24521094 |
---|---|
DOI: | 10.1016/j.adro.2021.100833 |